Skip to content
healthcare.dev

STEQEYMA

NDC 72606-029, ustekinumab-stba, injection, solution, from CELLTRION USA, Inc..

Product NDC
72606-029
Status
Listed
Labeler
CELLTRION USA, Inc.
Dosage form
INJECTION, SOLUTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA761338
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/72606-029 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • USTEKINUMAB130 mg/26mL

Pharmacologic classes

Interleukin-12 Antagonist [EPC]; Interleukin-12 Antagonists [MoA]; Interleukin-23 Antagonist [EPC]; Interleukin-23 Antagonists [MoA]

Package NDCNDC-11Package
72606-029-01726060029011 VIAL, SINGLE-USE in 1 CARTON (72606-029-01) / 26 mL in 1 VIAL, SINGLE-USE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/66085e17-e3f2-4196-8c81-87448e804b0c
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=72606-029

Use it

Look up 72606-029 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/72606-029 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 72606-029. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.